![Carol Stuckley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carol Stuckley
Directeur/Membre du Conseil chez
CENTESSA PHARMACEUTICALS PLC
Fortune : - $ au 31/05/2026
Profil
Carol Stuckley currently works at Transgene SA, as Independent Director from 2023 and Centessa Pharmaceuticals Plc, as Independent Non-Executive Director from 2021.
Ms. Stuckley also formerly worked at Ipsen SA, as Independent Director from 2017 to 2021, Epizyme, Inc., as Independent Director from 2021 to 2022, Financial Executives International of Fort Worth Chapter, as President & Director, Pfizer Inc., as Vice President-Finance & Assistant Treasurer, Galderma Laboratories LP, as Chief Financial Officer & Senior VP-Finance from 2010 to 2013, and Healthcare Payment Specialists LLC, as Chief Financial Officer & Senior Vice President from 2015 to 2019.
Ms. Stuckley received her undergraduate degree in 1977 from the University of Delaware and graduate degree in 1980 and Masters Business Admin degree in 1979 from Fox School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Carol Stuckley
| Sociétés | Poste | Début |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 17/05/2021 |
| TRANSGENE | Directeur/Membre du Conseil | 05/05/2023 |
Anciens postes connus de Carol Stuckley
| Sociétés | Poste | Fin |
|---|---|---|
| EPIZYME, INC. | Directeur/Membre du Conseil | 12/08/2022 |
| IPSEN | Directeur/Membre du Conseil | 01/08/2021 |
Healthcare Payment Specialists LLC
 Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Provides payment and reimbursement solutions | Directeur Financier/CFO | 01/07/2019 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Directeur Financier/CFO | 01/01/2013 |
Financial Executives International of Fort Worth Chapter | President | - |
Formation de Carol Stuckley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Provides payment and reimbursement solutions | Commercial Services |
Fox School of Business
 Fox School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Financial Executives International of Fort Worth Chapter | |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
